Balentine LLC’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$895K Buy
35,460
+391
+1% +$9.87K 0.03% 94
2026
Q1
$888K Buy
35,069
+12,424
+55% +$316K 0.04% 83
2025
Q4
$576K Buy
22,645
+344
+2% +$8.76K 0.02% 119
2025
Q3
$569K Buy
22,301
+198
+0.9% +$5.03K 0.02% 108
2025
Q2
$562K Buy
22,103
+13,991
+172% +$353K 0.02% 96
2025
Q1
$205K Buy
8,112
+61
+0.8% +$1.53K 0.01% 157
2024
Q4
$200K Buy
+8,051
New +$202K 0.01% 139

Other funds holding IBDT

Balentine LLC's IBDT Position: Q2 2026 in Review

Balentine LLC increased its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 1.1% in Q2 2026, buying an estimated $9.87K and bringing the position to 35,460 shares worth $895K. The position accounts for 0.03% of the portfolio, ranked #94.

Balentine LLC first reported a position in IBDT in Q4 2024 and has held it in 7 quarters since. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Balentine LLC held 35,460 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $895K as of Q2 2026.
  • Balentine LLC bought 391 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $9.87K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.03% of Balentine LLC's portfolio in Q2 2026, its #94 holding.
  • Balentine LLC first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Balentine LLC's 13F filing for Q2 2026, filed 6 Aug 2026.